Medical News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Prostate Cancer, Immunotherapy, Vista, MD Anderson Cancer Center

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Mar-2017 11:00 AM EDT

Medicine

Science

Channels:

Prenatal alcohol exposure, academic problems, Fetal Alcohol Spectrum Disorders , Brain Imaging, math performance, Brain Development In Children

Children Prenatally Exposed to Alcohol Have Academic Difficulties

Despite greater awareness of the dangers of prenatal exposure to alcohol, the rates of Fetal Alcohol Spectrum Disorders remain alarmingly high. This study evaluated academic achievement among children known to be prenatally exposed to maternal heavy alcohol consumption as compared to their peers without such exposure, and explored the brain regions that may underlie academic performance.

Medicine

Science

Channels:

women & drinking, Older Women, sensitivity to alcohol, Prescr, alcohol education, alcohol screening, Alcohol Treatment

An Increasing Proportion of Women Who Are 60 Years of Age and Older Are Drinking

Most older Americans drink alcohol. Given that this segment of the population is projected to almost double by 2050, reaching 112 million, in the future, there will likely be many more older drinkers in the United States than currently. Importantly, older individuals are more sensitive to alcohol’s effects than their younger counterparts, and are also more likely to take prescription medications that can interact negatively with alcohol, potentially leading to falls and other injuries. This study examined trends in drinking status among U.S. adults 60 years of age and older.

Medicine

Channels:

Diabetes, insulin spray, Insulin, Cognitive Decline, Mild Cognitive Impairment, Memory, Aging, Alzheimer's Disease

Sniffing Out a New Strategy Against Alzheimer’s Disease

Neurologists at the Rush Alzheimer’s Disease Center are conducting an 18-month clinical trial testing a type of insulin delivered in a nasal spray – which is used to treat diabetes in some patients – in the Study of Nasal Insulin to Fight Forgetfulness (SNIFF).

Medicine

Channels:

cancer immunotherapy, Merkel cell carcinoma , MCC, Paul Nghiem, avelumab , bavencio, Skin Cancer, Fred Hutch

Immunotherapy Drug Becomes First Therapy Approved by FDA for Rare Skin Cancer

Paul_Nghiem_19349.JPG

The U.S. Food and Drug Administration yesterday granted accelerated approval to the checkpoint inhibitor Bavencio (avelumab) for the treatment of patients with metastatic Merkel cell carcinoma. Dr. Paul Nghiem, a senior investigator on the clinical trial that led to yesterday’s fast-track FDA approval and an expert on MCC is available for interviews, as is a patient who participated in the clinical trial.

Medicine

Channels:

Which Drugs Effectively Treat Diabetic Nerve Pain?

A federal health agency has found certain antidepressants and anti-seizure drugs are among medications that effectively treat diabetic nerve pain. The research is being published simultaneously in the March 24, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology (AAN) and in a more comprehensive report by the Agency for Healthcare Research and Quality (AHRQ).

Medicine

Life

Social and Behavioral Sciences

Channels:

Obesity, Diet, Healthy Snacks, vending machines, snack habits, behavioral and social science

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 31-Mar-2017 10:00 AM EDT

Medicine

Channels:

Children, Exercise, Heart Disease, metabolic biomarkers

A Little Vigorous Exercise May Help Boost Kids’ Cardiometabolic Health

As little as 10 minutes a day of high-intensity physical activity could help some children reduce their risk of developing heart problems and metabolic diseases such as diabetes, according to an international study led by a researcher at Wake Forest Baptist Medical Center.

Medicine

Channels:

Andrew Feinberg, DNA, Cancer, Randomness, Epigenetic, Genome

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Mar-2017 11:00 AM EDT

Medicine

Channels:

HIV, AIDS, Prevention

UNC to Create and Test Injectable Long-Acting Implant to Prevent HIV/AIDS

MartinaKovaRova.jpg

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention.







Chat now!